| Complete heart block in association with graft-versus-host disease. | |
| | |
MedLine Citation:
|
PMID: 9486500 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
An infant who received haploidentical BM for severe combined immunodeficiency (SCID) developed acute, reversible complete heart block in association with an exacerbation of GVHD. Respiratory distress and myocardial dysfunction were also seen with this and previous GVHD exacerbations. The patient had not received chemotherapy or radiation prior to BMT. The complete heart block resolved after 1 week of intensive immunosuppression. The association of complete heart block with GVHD is important because the heart block is potentially reversible with prompt, aggressive control of the GVHD. |
| | |
Authors:
|
A L Gilman; N W Kooy; D L Atkins; Z Ballas; S Rumelhart; M Holida; N Lee; F Goldman |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: Bone marrow transplantation Volume: 21 ISSN: 0268-3369 ISO Abbreviation: Bone Marrow Transplant. Publication Date: 1998 Jan |
Date Detail:
|
Created Date: 1998-03-26 Completed Date: 1998-03-26 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 8702459 Medline TA: Bone Marrow Transplant Country: ENGLAND |
Other Details:
|
Languages: eng Pagination: 85-8 Citation Subset: IM |
Affiliation:
|
Division of Hematology/Oncology, Department of Pediatrics, University of Iowa College of Medicine, Iowa City, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Bone Marrow Transplantation
/
adverse effects* Graft vs Host Disease / complications* Heart Block / etiology* Humans Immunosuppressive Agents / therapeutic use Infant Male |
| Chemical | |
Reg. No./Substance:
|
0/Immunosuppressive Agents |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Cadaveric bone marrow and spleen cells for transplantation.
Next Document: Trichomonas foetus meningoencephalitis after allogeneic peripheral blood stem cell transplantation.